PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety, speed of absorption, and onset of action of
G-Pump™ (glucagon infusion) at three subcutaneous doses as compared to Novo GlucaGen®, all
delivered via an OmniPod® infusion pump to patients with type 1 diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
Xeris Pharmaceuticals
Collaborators:
Emissary International LLC National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)